Chronic hepatitis C virus (HCV) disease burden and cost in the United States†
Version of Record online: 6 MAY 2013
Copyright © 2013 American Association for the Study of Liver Diseases
Volume 57, Issue 6, pages 2164–2170, June 2013
How to Cite
Razavi, H., ElKhoury, A. C., Elbasha, E., Estes, C., Pasini, K., Poynard, T. and Kumar, R. (2013), Chronic hepatitis C virus (HCV) disease burden and cost in the United States. Hepatology, 57: 2164–2170. doi: 10.1002/hep.26218
Potential conflict of interest: Authors 1Received funding for this project from Merck & Co. Inc.; 2Employee of Merck & Co. Inc.; 3Consulted with Merck, Roche, Vertex, and Gilead. Dr. ElKhoury owns stock in Merck.
- Issue online: 12 JUN 2013
- Version of Record online: 6 MAY 2013
- Accepted manuscript online: 22 DEC 2012 08:53AM EST
- Manuscript Accepted: 10 DEC 2012
- Manuscript Received: 3 SEP 2012
Additional Supporting Information may be found in the online version of this article.
|HEP_26218_sm_SuppFigA.tif||469K||Supporting Information Figure Appendix A.|
|HEP_26218_sm_SuppFigC.tif||271K||Supporting Information Figure Appendix C.|
Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.